SCHEMBL18876636

SCHEMBL18876636

CCN(Cc1ccnc(C)c1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ2 O43526 1/20 0.39
▸ UHRF1 Q96T88 1/20 0.38
▸ NOS3 P29474 1/20 0.37
▸ NOS1 P29475 1/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ TYMS P04818 2/20 0.36
▸ ADAMTS4 O75173 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ GRM5 P41594 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ CYP2D6 P10635 2/20 0.34
▸ KCNE1 P15382 1/20 0.34
▸ KCNA5 P22460 1/20 0.34
▸ AAK1 Q2M2I8 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18876832 0.82 LOX (0.47) NOS3NOS1NOS2PDGFRBKDR
SCHEMBL20892138 0.80 NOS3 (0.44) NOS3NOS1NOS2PDGFRBKDR
SCHEMBL17286028 0.77 CHRNB2 (0.49) KCNQ2UHRF1NOS3NOS1NOS2
SCHEMBL10240740 0.77 HSD17B10 (0.41) CYP2D6CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL212981 0.76 — —
SCHEMBL29371239 0.76 — —
SCHEMBL14613356 0.74 UHRF1 (0.46) KCNQ2UHRF1NOS1TYMSGRM5
Hydrochloric Acid SCHEMBL11413047 0.74 NOS3 (0.57) KCNQ2UHRF1NOS3NOS1NOS2
SCHEMBL17282090 0.73 UHRF1 (0.38) KCNQ2UHRF1NOS3NOS1NOS2
SCHEMBL20909891 0.73 UHRF1 (0.38) UHRF1NOS3NOS1NOS2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190322661-A1 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2019-10-24 — — US disclosed
US-20170145020-A1 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322661-A1 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF ABL1, JAK2, FLT3 KCNQ2 1242/4885UHRF1 3242/4885NOS3 3306/4885
US-20170145020-A1 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF ABL1, JAK2, FLT3 KCNQ2 1242/4885UHRF1 3242/4885NOS3 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback